BIOREM Inc.
BIRMF
$1.66
-$0.14-7.78%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 165.70% | 67.45% | 87.33% | 11.62% | -26.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 165.70% | 67.45% | 87.33% | 11.62% | -26.66% |
| Cost of Revenue | 144.65% | 66.55% | 36.01% | 11.13% | -19.48% |
| Gross Profit | 219.78% | 70.63% | 1,426.13% | 12.49% | -40.33% |
| SG&A Expenses | 147.62% | 32.85% | 30.95% | -45.95% | -41.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -500.00% | -- |
| Total Operating Expenses | 144.97% | 59.96% | 35.19% | -3.82% | -24.49% |
| Operating Income | 297.32% | 340.66% | 169.80% | 117.40% | -37.96% |
| Income Before Tax | 328.51% | 445.85% | 161.92% | 136.56% | -35.71% |
| Income Tax Expenses | 328.62% | 445.56% | 161.95% | 39.88% | -35.71% |
| Earnings from Continuing Operations | 328.47% | 445.82% | 161.91% | 194.64% | -35.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 328.47% | 445.82% | 161.91% | 194.64% | -35.70% |
| EBIT | 297.32% | 340.66% | 169.80% | 117.40% | -37.96% |
| EBITDA | 295.77% | 240.68% | 187.93% | 113.40% | -39.83% |
| EPS Basic | 325.52% | 443.48% | 161.98% | 188.56% | -36.44% |
| Normalized Basic EPS | 326.11% | 446.15% | 161.71% | 131.65% | -36.56% |
| EPS Diluted | 286.16% | 386.96% | 153.01% | 206.16% | -27.04% |
| Normalized Diluted EPS | 302.75% | 392.31% | 153.60% | 173.74% | -38.10% |
| Average Basic Shares Outstanding | 0.65% | 0.00% | 0.00% | 2.02% | 1.29% |
| Average Diluted Shares Outstanding | 6.52% | 18.01% | 15.37% | -13.62% | 3.61% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
